Bausch Health is targeting 2026 revenues of $5.525-5.625 billion, as it charts the headwinds of Xifaxan (NYSE:BHC) for the fourth quarter.
Bausch Health is targeting 2026 revenues of $5.525-5.625 billion, as it charts the headwinds of Xifaxan (NYSE:BHC) for the fourth quarter.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in